The stimulative function of long noncoding RNA CDKN2B-AS1 in osteosarcoma by targeting the microRNA-122/CCNG1 axis

References

• Otoukesh B, Boddouhi B, Moghtadaei M, et al. Novel molecular insights and new therapeutic strategies in osteosarcoma. Cancer Cell Int. 2018;18:158.
   PubMed Web of Science ®Google Scholar
• Jones KB. Osteosarcomagenesis: modeling cancer initiation in the mouse. Sarcoma. 2011;2011:694136.
   PubMedGoogle Scholar
• Ta HT, Dass CR, Choong PF, et al. Osteosarcoma treatment: state of the art. Cancer Metastasis Rev. 2009;28(1-2):247–263.
   PubMed Web of Science ®Google Scholar
• Abarrategi A, Tornin J, Martinez-Cruzado L, et al. Osteosarcoma: cells-of-origin, cancer stem cells, and targeted therapies. Stem Cells Int. 2016;2016:3631764.
   PubMed Web of Science ®Google Scholar
• Wang JY, Yang Y, Ma Y, et al. Potential regulatory role of lncRNA-miRNA-mRNA axis in osteosarcoma. Biomed Pharmacother. 2020;121:109627.
   PubMed Web of Science ®Google Scholar
• Wang Y, Huang Y, Liu H, et al. Long noncoding RNA CDKN2B-AS1 interacts with miR-411-3p to regulate ovarian cancer in vitro and in vivo through HIF-1a/VEGF/P38 pathway. Biochem Biophys Res Commun. 2019;514(1):44–50.
   PubMed Web of Science ®Google Scholar
• Huang Y, Xiang B, Liu Y, et al. LncRNA CDKN2B-AS1 promotes tumor growth and metastasis of human hepatocellular carcinoma by targeting let-7c-5p/NAP1L1 axis. Cancer Lett. 2018;437:56–66.
   PubMed Web of Science ®Google Scholar
• Cui X, Yu T, Shang J, et al. Long non-coding RNA CDKN2B-AS1 facilitates laryngeal squamous cell cancer through regulating miR-497/CDK6 pathway. Onco Targets Ther. 2019;12:8853–8862.
   PubMed Web of Science ®Google Scholar
• Luo Y, Tao H, Jin L, et al. CDKN2B-AS1 exerts oncogenic role in osteosarcoma by promoting cell proliferation and epithelial to mesenchymal transition. Cancer Biother Radiopharm. 2020;35(1):58–65.
   PubMed Web of Science ®Google Scholar
• Ma J, Li T, Han X, et al. Knockdown of LncRNA ANRIL suppresses cell proliferation, metastasis, and invasion via regulating miR-122-5p expression in hepatocellular carcinoma. J Cancer Res Clin Oncol. 2018;144(2):205–214.
   PubMed Web of Science ®Google Scholar
• Li C, Hu G, Wei B, et al. lncRNA LINC01494 promotes proliferation, migration and invasion in glioma through miR-122-5p/CCNG1 axis. Onco Targets Ther. 2019;12:7655–7662.
   PubMedGoogle Scholar
• Xu Y, Zhang Q, Miao C, et al. CCNG1 (Cyclin G1) regulation by mutant-P53 via induction of Notch3 expression promotes high-grade serous ovarian cancer (HGSOC) tumorigenesis and progression. Cancer Med. 2019;8(1):351–362.
   PubMed Web of Science ®Google Scholar
• Wen W, Han T, Chen C, et al. Cyclin G1 expands liver tumor-initiating cells by Sox2 induction via Akt/mTOR signaling. Mol Cancer Ther. 2013;12(9):1796–1804.
   PubMed Web of Science ®Google Scholar
• Wu B, Xing C, Tao J. Upregulation of microRNA-23b-3p induced by farnesoid X receptor regulates the proliferation and apoptosis of osteosarcoma cells. J Orthop Surg Res. 2019;14(1):398.
   PubMed Web of Science ®Google Scholar
• Qi X, Yu XJ, Wang XM, et al. Knockdown of KCNQ1OT1 suppresses cell invasion and sensitizes osteosarcoma cells to CDDP by upregulating DNMT1-mediated Kcnq1 expression. Mol Ther Nucleic Acids. 2019;17:804–818.
   PubMedGoogle Scholar
• Forrest ME, Khalil AM. Review: regulation of the cancer epigenome by long non-coding RNAs. Cancer Lett. 2017;407:106–112.
   PubMed Web of Science ®Google Scholar
• Quinn JJ, Chang HY. Unique features of long non-coding RNA biogenesis and function. Nat Rev Genet. 2016;17(1):47–62.
   PubMed Web of Science ®Google Scholar
• Wan G, Mathur R, Hu X, et al. Long non-coding RNA ANRIL (CDKN2B-AS) is induced by the ATM-E2F1 signaling pathway. Cell Signal. 2013;25(5):1086–1095.
   PubMed Web of Science ®Google Scholar
• Zhang EB, Kong R, Yin DD, et al. Long noncoding RNA ANRIL indicates a poor prognosis of gastric cancer and promotes tumor growth by epigenetically silencing of miR-99a/miR-449a. Oncotarget. 2014;5(8):2276–2292.
   PubMedGoogle Scholar
• Wei X, Wang C, Ma C, et al. Long noncoding RNA ANRIL is activated by hypoxia-inducible factor-1alpha and promotes osteosarcoma cell invasion and suppresses cell apoptosis upon hypoxia. Cancer Cell Int. 2016;16:73.
   PubMed Web of Science ®Google Scholar
• Yu F, Pang G, Zhao G. RETRACTED: ANRIL acts as onco-lncRNA by regulation of microRNA-24/c-Myc, MEK/ERK and Wnt/β-catenin pathway in retinoblastoma. Int J Biol Macromol. 2019;128:583–592.
   PubMed Web of Science ®Google Scholar
• Cheng S, Huang T, Li P, et al. Long non-coding RNA ANRIL promotes the proliferation, migration and invasion of human osteosarcoma cells. Exp Ther Med. 2017;14(5):5121–5125.
   PubMed Web of Science ®Google Scholar
• Shi D, Wu F, Mu S, et al. LncRNA AFAP1-AS1 promotes tumorigenesis and epithelial-mesenchymal transition of osteosarcoma through RhoC/ROCK1/p38MAPK/Twist1 signaling pathway. J Exp Clin Cancer Res. 2019;38(1):375.
   PubMed Web of Science ®Google Scholar
• Shi X, Sun M, Liu H, et al. Long non-coding RNAs: a new frontier in the study of human diseases. Cancer Lett. 2013;339(2):159–166.
   PubMed Web of Science ®Google Scholar
• Zhang LM, Ju HY, Wu YT, et al. Long non-coding RNA ANRIL promotes tumorgenesis through regulation of FGFR1 expression by sponging miR-125a-3p in head and neck squamous cell carcinoma. Am J Cancer Res. 2018;8:2296–2310.
   PubMed Web of Science ®Google Scholar
• Chen J, Huang X, Wang W, et al. LncRNA CDKN2BAS predicts poor prognosis in patients with hepatocellular carcinoma and promotes metastasis via the miR-153-5p/ARHGAP18 signaling axis. Aging (Albany NY). 2018;10(11):3371–3381.
   PubMedGoogle Scholar
• Wang X, Zhang X, Han Y, et al. Silence of lncRNA ANRIL represses cell growth and promotes apoptosis in retinoblastoma cells through regulating miR-99a and c-Myc. Artif Cells Nanomed Biotechnol. 2019;47(1):2265–2273.
   PubMed Web of Science ®Google Scholar
• Gui D, Cao H. Long non-coding RNA CDKN2B-AS1 promotes osteosarcoma by increasing the expression of MAP3K3 via sponging miR-4458. In Vitro Cell Dev Biol Anim. 2020;56(1):24–33.
   PubMed Web of Science ®Google Scholar
• Heinemann FG, Tolkach Y, Deng M, et al. Serum miR-122-5p and miR-206 expression: non-invasive prognostic biomarkers for renal cell carcinoma. Clin Epigenetics. 2018;10:11.
   PubMed Web of Science ®Google Scholar
• Ma J, Wu Q, Zhang Y, et al. MicroRNA sponge blocks the tumor-suppressing functions of microRNA-122 in human hepatoma and osteosarcoma cells. Oncol Rep. 2014;32(6):2744–2752.
   PubMed Web of Science ®Google Scholar
• Gong L, Zhu H, Li T, et al. Molecular signatures of cytotoxic effects in human embryonic kidney 293 cells treated with single and mixture of ochratoxin A and citrinin. Food Chem Toxicol. 2019;123:374–384.
   PubMed Web of Science ®Google Scholar
• Ma L, Liu J, Shen J, et al. Expression of miR-122 mediated by adenoviral vector induces apoptosis and cell cycle arrest of cancer cells. Cancer Biol Ther. 2010;9(7):554–561.
   PubMed Web of Science ®Google Scholar
• Ye XX, Liu CB, Chen JY, et al. The expression of cyclin G in nasopharyngeal carcinoma and its significance. Clin Exp Med. 2012;12(1):21–24.
   PubMed Web of Science ®Google Scholar
• Han H, Zhang Z, Yang X, et al. miR-23b suppresses lung carcinoma cell proliferation through CCNG1. Oncol Lett. 2018;16(4):4317–4324.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Wang Y, Xing G. miR-516b functions as a tumor suppressor by directly modulating CCNG1 expression in esophageal squamous cell carcinoma. Biomed Pharmacother. 2018;106:1650–1660.
   PubMed Web of Science ®Google Scholar
• Lin T, Ma Q, Zhang Y, et al. MicroRNA-27a functions as an oncogene in human osteosarcoma by targeting CCNG1. Oncol Lett. 2018;15(1):1067–1071.
   PubMed Web of Science ®Google Scholar
• Huang CS, Chu J, Zhu XX, et al. The C/EBPβ-LINC01133 axis promotes cell proliferation in pancreatic ductal adenocarcinoma through upregulation of CCNG1. Cancer Lett. 2018;421:63–72.
   PubMed Web of Science ®Google Scholar